Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial
UK-based biotech Scancell developed its off-the-shelf DNA vaccine – dubbed iSCIB1+ – to help improve the recognition of cancer cells by the patient's immune system, which enhances response to immunotherapy treatments. The vaccine uses a needle-free injection device system and is administered for up to 85 weeks.
Shares in London-listed Scancell were up 6% at market open today (14 April) following the news. The company has a market cap of £102.1m.
The clinical trial (NCT04079166) is part of the NHS Cancer Vaccine Launch Pad (CVLP), a framework launched in May 2024 to help fast-track eligible patients into studies at nearby hospitals evaluating vaccines against cancers. It is part of a government push to boost the medical research landscape in the UK.
The Phase II study, called SCOPE, is already underway and is slated to enrol more than 140 patients. The first referrals for patients who are part of the CVLP fast-track are expected next month. Southampton Clinical Trials Unit has agreed to be the trial site for the CVLP partnership with Scancell.
Scancell stated that data from one of the cohorts in the trial, who received a first iteration of the vaccine alongside two checkpoint inhibitors, demonstrated an 80% progression-free survival (PFS) and 20% complete response rate (CR). Other cohorts are testing the latest generation of the vaccine, in addition to evaluating an intradermal administration route. The first clinical data from iSCIB1+ is expected in mid-2025.
Melanoma is the fifth most common cancer in the UK, accounting for around 4% of all new cancer cases. Around half of melanoma patients respond to standard care of immunotherapy, but those who do not are at higher risk of cancer progression. iSCIB1+, developed using Scancell's Immunobody DNA vaccine platform, targets activated antigen-presenting cells via CD64 and activates T cells. According to the biotech, this creates an immune memory that prevents the cancer from recurring.
The SCOPE trial is the latest expansion of the CVLP. Its debut last year marked the start of a clinical trial sponsored by BioNTech that is fast-tracking access to the company's personalised mRNA vaccine against bowel cancer in an ongoing study. The NHS stated that more than 350 patients have been referred for consideration to date.
'It's incredibly exciting that the NHS is expanding its world-leading programme so more patients with different types of cancer could benefit from the development of new vaccines that could stop their cancer coming back,' said Professor Peter Johnson, the NHS' national cancer director.
'We want to ensure as many eligible NHS patients as possible have access to these vital trials, which is why we are working with a range of industry partners as more studies get up and running to ensure patients are fast-tracked to a vaccine that could transform lives.'
Scancell's chief medical officer Dr Nermeen Varawalla said: 'Cancer vaccines have the potential to transform immunotherapy, redefine treatment options and ultimately save lives.
"Recent clinical data has demonstrated that our potent, tumour-targeted 'off-the-shelf' cancer vaccine delivers strong efficacy, with the potential for meaningful long-term survival benefits in patients with advanced metastatic melanoma.'
"Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
The Reason Why Everyone's Confused About UPFs – and What the Current Science Actually Says
The term 'ultra-processed food' (or UPF, for short) has launched into the nutritional spotlight in recent years, with study after study linking the food group to obesity, heart disease, type 2 diabetes, and a multitude of other chronic conditions. And in the UK, we eat a lot of ultra-processed foods. A recent landmark study showed that UPFs made up a whopping 53% of people's energy intake in the UK, coming second only to the US, where UPFs comprised 55%. This trend has led some researchers to claim that ultra-processed foods are 'a primary causal driver of the obesity pandemic'. But is the study of ultra-processed food actually a genuine scientific breakthrough in understanding diet and disease? Or is it just a fancy new label for foods we already knew were unhealthy? What we know now is there's a lack of a clear definition for ultra-processed foods – and we could sure use one. What Are Ultra-processed Foods? The definition of ultra-processed foods has shifted a bit since the term was first coined by Brazilian researchers in 2009, but now the term basically involves a food product meeting two specific criteria. The first is that the main components of the food are a result of multiple stages of industrial processing. Examples: white sugar, white flour, vegetable oil. The second is that the food has additives not commonly used in at-home cooking. This includes preservatives like BHT, emulsifiers like soy lecithin, stabilising agents like modified corn starch, food dyes, thickening agents, and the ever mysterious 'artificial flavours'. That's a tough definition for the average person to remember, understand, and apply to their food choices. Research actually bears this out. Even people who claim to know what ultra-processed foods are often misidentify which foods are actually ultra-processed. To make things even more confusing, some foods fall into an ultra-processed grey area. Let's take bacon, for example. While bacon certainly has additives thanks to its preservatives, whether it undergoes multiple stages of industrial processing is more nebulous. As a result, bacon has been classified as ultra-processed in some scientific papers, but not ultra-processed in others. Whole-grain bread, certain aged cheeses, and tomato sauce – healthy by most definitions – have also been slapped with an ultra-processed label, only adding to consumer confusion. The (New) Science for Ultra-processed Foods Not only is the definition of ultra-processing a bit fuzzy, there's also some debate as to why ultra-processed foods promote worse health outcomes in the first place. Because not all ultra-processed foods are harmful (see whole-grain bread and tomato sauce, but also yoghurt and dark chocolate), researchers have tried to explain why only some foods categorised as ultra-processed are linked to disease. One hypothesis is that (of all things) eating speed is a central factor. Due to their processing, ultra-processed foods are often softer and easier to chew (think peanut butter vs. peanuts), which makes people eat them faster. Rapid consumption may outpace the brain's ability to signal fullness, causing people to overeat, which may eventually lead to obesity and its associated diseases. But this is only a guess. The science that has been done on eating speed as a major factor in overeating tends to be underwhelming. Another hypothesis is that food additives are the key. Some research suggests that emulsifiers commonly found in UPFs (including polysorbate 80 and carboxymethylcellulose) might harm gut health and set off a cascade of inflammation leading to disease, or that taste enhancers, like MSG and added flavours, might override satiety signals and promote overeating. But the existing evidence for these claims is weak. Plus, given that there are hundreds (if not thousands) of food additives in use, studying the long-term effects of individual additives is challenging. But here's another take: The problem with ultra-processed foods might not be due to ultra-processing at all. The (Old) Science Behind Ultra-processing and Health Before ultra-processed food was ever a buzzword, research had established that certain processed foods were low in beneficial nutrients (fibre, potassium) and high in other not-so-great-for-you things like saturated fat, sugar, and salt. This nutritional imbalance alone could explain why ultra-processed foods are dangerous for our health – with no need to bring processing into the discussion. In fact, when studies have actually analysed ultra-processed foods separately, the biggest offenders for health tend to be soda, processed meat products like hot dogs, take-out style foods like pizza and french fries, and refined grains. These are foods that most dietary guidelines and health professionals have long recommend limiting. Given this, perhaps avoiding ultra-processed foods is just a modern repackaging of the same dietary advice we've heard a million times before. So where does that leave us now –and for the future? The Path Forward for Ultra-processed Food There's a real concern over the lack of clear definition for 'ultra-processed foods'. We've seen it before with health buzzwords like 'healthy', 'all-natural', and 'plant-based'. If ultra-processed food means many different things, does it mean anything at all? After decades of fixating on individual nutrients – from fat and cholesterol to carbohydrates and gluten – it's certainly refreshing that the discussion around ultra-processed foods is a more top-down approach to figuring out what makes us sick. But it's far from perfect right now. You Might Also Like The 23 Best Foods to Build Muscle 10 of the Best Waterproof Boots to Buy in 2019 6 Ways to Improve Your Mental Health
Yahoo
an hour ago
- Yahoo
Experts thrilled after capturing footage of massive ocean creature in unexpected location: 'This is a really exciting spot'
Experts thrilled after capturing footage of massive ocean creature in unexpected location: 'This is a really exciting spot' A rare humpback whale was spotted off the British coast of Kent, according to the BBC. The sighting was reported to the Kent Dolphin Project, which solicits local footage of whales, porpoises, and dolphins to monitor population health. Volunteers were quite excited by the find. Humpback whales were previously endangered, but conservation efforts have helped populations rebound. There have been other recent sightings of humpbacks in Cornwall and Sussex (you can see footage of this particular sighting here, via the BBC). Humpback whales serve a vital purpose in oceanic ecosystems. As predators, they keep prey populations like krill in check. The waste they produce feeds phytoplankton, which serve a vital role in sequestering carbon. Whales themselves are so massive that their bodies sequester a significant amount of carbon. That carbon can stay locked below the waves when they die and sink to the ocean floor. While the sighting is good news, some threats linger. Ghost netting continues to be a threat to humpbacks in the area. Warming surface temperatures are disorienting them. Ship strikes cause a lot of harm. The Kent Wildlife Trust is using the fresh sighting to fight plans to install new undersea cabling. The Sea Link project will, on the one hand, help transmit low-emission energy from production to the British public. Similar UK projects have aimed to connect growing wind power to the grid. On the other hand, the cables may interfere with wildlife such as humpback whales and dolphins that traverse the area. Activists remained excited about the sighting of the humpback whale in Kent. It could prove the growing health of the lengthy Atlantic migration routes. "This is a really exciting spot," said Max Renton from Adonis Blue Environmental Consultants on the footage. "While it's not yet possible to confirm whether these are the same individuals, sightings like these highlight the importance of ongoing efforts to understand and protect our marine life." Do you think America has a plastic waste problem? Definitely Only in some areas Not really I'm not sure Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword
Epoch Times
an hour ago
- Epoch Times
FDA Advises Americans Against ‘Mousse' Sunscreens, Warns 5 Manufacturers
Americans should 'beware' of sunscreen products in mousse form as they may not be effective, the Food and Drug Administration (FDA) said in an Aug. 12 X post, with the agency sending warning letters to five companies marketing sunscreen products. The letters were sent on Aug. 6 to Texas-based Supergoop, Pennsylvania-based Fallien Cosmeceuticals Ltd., Israel-based K & Care Organics, Sweden-based Kalani AB, and Florida-based Vacation Inc.
